Skip to main content

Statewide System and Organizational Strategy for Evidence-Based Practice Implementation and Sustainment in Substance Use Disorder Treatment

Principal Investigator(s): Gregory Aarons, Ph.D. UC San Diego

Co-Investigators(s): Mark Ehrhart, Ph.D. Univeristy of Central Florida, Marisa Sklar, Ph.D. UC San Diego

This project will test an implementation strategy that seeks to align system, organization, and clinic leadership and strategies to implement and sustain an evidence-based practice (EBP) for substance use disorders. The Leadership and Organizational Change for Implementation - System Level (LOCI-SL) seeks to improve implementation leadership, climate, provider attitudes and behaviors, and EBP fidelity for enhanced client engagement in services and outcomes. LOCI-SL will be tested in integrated mental health and substance use disorder treatment clinics across the state of Oregon while engaging the Oregon Health Authority, the Alcohol and Drug Policy Commission, and managed care organizations.

Funding Information: NIH/NIDA,

Study time period: 2020 - 2025

NIH RePORTER

Project Website

Policy Dissemination Strategies to Improve the Use of Research Evidence in Medicaid Benefits for Opioid Use Disorder Treatment

Principal Investigator: Erika Crable, Ph.D. UC San Diego

More than one-third of Americans living with an opioid use disorder are publicly insured by state Medicaid or Children’s Health Insurance Plan (CHIP), but many of these state programs fail to provide sufficient access to lifesaving medications for opioid use disorder (MOUD). Research is critically needed to understand how policymakers overseeing Medicaid/CHIP benefit arrays solicit, receive, and use evidence to define their benefit and utilization management policies for MOUD.

This study will advance policy dissemination science methods to:

  1. Develop and administer a national survey to Medicaid/CHIP agency and MCO policymakers to identify determinants, mechanisms, and intermediaries that influence their evidence use behaviors.
  2. Empirically identify and describe distinct subgroups of Medicaid/CHIP agencies and MCOs based on their evidence use behaviors when designing MOUD benefits.
  3. Design and pilot test the acceptability, appropriateness and feasibility of dissemination strategies, tailored to each latent class, for promoting policymakers’ evidence-based decision-making regarding MOUD benefits.

Funding Information: NIDA, K01, 1K01DA056838-01

Study time period: 2022 - 2027

NIH RePORTER

Study Protocol Citation